elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-0D8F90FE-63B2-480B-A01D-47CB5E2571A2
Q27852097-0D8F90FE-63B2-480B-A01D-47CB5E2571A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-0D8F90FE-63B2-480B-A01D-47CB5E2571A2
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P2093
Q27852097-0D8F90FE-63B2-480B-A01D-47CB5E2571A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-0D8F90FE-63B2-480B-A01D-47CB5E2571A2
rank
NormalRank
type
BestRank
Statement
P1545
2
http://www.w3.org/2001/XMLSchema#string
P2093
Daniel D Von Hoff
http://www.w3.org/2001/XMLSchema#string